Equine models in translational medicine: A comparative approach to human health

Abstract

The horse is a distinctive translational model for bridging mechanistic discovery and clinically relevant investigation because of its physiological complexity, long lifespan, athletic phenotype, and broad spectrum of naturally occurring conditions that parallel aspects of human health and disease. Its utility extends from musculoskeletal and joint research to immunology, metabolic disorders, and exercise physiology, particularly where naturally developed disease, clinically applicable imaging, and longitudinal sampling are required. Additionally, it offers opportunities to examine both chronic and acute pathological processes in a setting that closely approximates clinical reality. Advances in molecular profiling, imaging technologies, and biomarker discovery have expanded the scope of equine-based studies, enabled refined mechanistic insights, and facilitated translational strategies. The integration of equine research into comparative medicine frameworks holds promise for accelerating therapeutic innovation within comparative and One-Health, improving health outcomes across species.

Keywords

animal models / comparative medicine / equine model / One Health / translational research

References

[1] Denayer T, Stöhr T, Van Roy M. Animal models in translational medicine: validation and prediction. Eur J Mol Clin Med. 2014; 2(1): 5-11.

[2] Steger-Hartmann T, Raschke M. Translating in vitro to in vivo and animal to human. Curr Opin Toxicol. 2020; 23-24: 6-10.

[3] Blanset D, Hutt J, Morgan S. Current use of animal models of disease for nonclinical safety testing. Curr Opin Toxicol. 2020; 23-24: 11-16.

[4] Kaplan BLF, Hoberman AM, Slikker W Jr, et al. Protecting human and animal health: the road from animal models to new approach methods. Pharmacol Rev. 2024; 76(2): 251-266.

[5] Farooqi IS, Xu Y. Translational potential of mouse models of human metabolic disease. Cell. 2024; 187(16): 4129-4143.

[6] Durward-Akhurst SA, Marlowe JL, Schaefer RJ, et al. Predicted genetic burden and frequency of phenotype-associated variants in the horse. Sci Rep. 2024; 14(1):8396.

[7] Danek M, Danek J, Araszkiewicz A. Large animals as potential models of human mental and behavioral disorders. Psychiatr Pol. 2017; 51(6): 1009-1027.

[8] Fureix C, Jego P, Henry S, Lansade L, Hausberger M. Towards an ethological animal model of depression? A study on horses. PLoS One. 2012; 7(6):e39280.

[9] Carnevale E. The mare model for follicular maturation and reproductive aging in the woman. Theriogenology. 2008; 69(1): 23-30.

[10] Aleman M, McCue M, Bellone RR. Allele frequencies and genotypes for the ryanodine receptor 1 variant causing malignant hyperthermia and fatal rhabdomyolysis with hyperthermia in horses. J Vet Intern Med. 2025; 39(3):e70081.

[11] Winters R, Masood S. Waardenburg syndrome. StatPearls [Internet]. StatPearls Publishing; 2025. https://www.ncbi.nlm.nih.gov/books/NBK560879/

[12] Reiter S, Wallner B, Brem G, et al. Distribution of the warmblood fragile foal syndrome type 1 mutation (PLOD1 c.2032G>A) in different horse breeds from Europe and the United States. Genes. 2020; 11(12):1518.

[13] Rohrbach M, Giunta C. PLOD1-related kyphoscoliotic Ehlers-Danlos syndrome. In: MP Adam, J Feldman, GM Mirzaa, et al., eds. GeneReviews® [Internet]. University of Washington, Seattle; 1993–2025. 2000. https://www.ncbi.nlm.nih.gov/books/NBK1462/.

[14] Patterson-Kane JC, Rich T. Achilles tendon injuries in elite athletes: lessons in pathophysiology from their equine counterparts. ILAR J. 2014; 55(1): 86-99.

[15] McIlwraith CW, Frisbie DD, Kawcak CE. The horse as a model of naturally occurring osteoarthritis. Bone Joint Res. 2012; 1(11): 297-309.

[16] Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019; 393: 1745-1759.

[17] McIlwraith CW, Kawcak CE, Frisbie DD, et al. Biomarkers for equine joint injury and osteoarthritis. J Orthop Res. 2018; 36(3): 823-831.

[18] McIlwraith CW, Frisbie DD, Kawcak CE, Fuller CJ, Hurtig M, Cruz A. The OARSI histopathology initiative—recommendations for histological assessments of osteoarthritis in the horse. Osteoarthr Cartil. 2010; 18(Suppl 3): S93-S105.

[19] Mahmoudian A, Lohmander LS, Mobasheri A, Englund M, Luyten FP. Early-stage symptomatic osteoarthritis of the knee—time for action. Nat Rev Rheumatol. 2021; 17(10): 621-632.

[20] Couëtil LL, Cardwell JM, Gerber V, Lavoie JP, Léguillette R, Richard EA. Inflammatory airway disease of horses—revised consensus statement. J Vet Intern Med. 2016; 30(2): 503-515.

[21] Bullone M, Lavoie JP. The equine asthma model of airway remodeling: from a veterinary to a human perspective. Cell Tissue Res. 2020; 380(2): 223-236.

[22] Hesselkilde EZ, Carstensen H, Haugaard MM, et al. Effect of flecainide on atrial fibrillatory rate in a large animal model with induced atrial fibrillation. BMC Cardiovasc Disord. 2017; 17(1):289.

[23] Hesselkilde EZ, Carstensen H, Flethøj M, et al. Longitudinal study of electrical, functional and structural remodelling in an equine model of atrial fibrillation. BMC Cardiovasc Disord. 2019; 19(1):228.

[24] Van Loon G, Duytschaever M, Tavernier R, Fonteyne W, Jordaens L, Deprez P. An equine model of chronic atrial fibrillation: methodology. Vet J. 2002; 164(2): 142-150.

[25] Harman RM, Theoret CL, de Van Walle GR. The horse as a model for the study of cutaneous wound healing. Adv Wound Care. 2019; 10(7): 381-399.

[26] Theoret CL, Olutoye OO, Parnell LK, Hicks J. Equine exuberant granulation tissue and human keloids: a comparative histopathologic study. Vet Surg. 2013; 42(7): 783-789.

[27] Smith RK, Garvican ER, Fortier LA. The current ‘state of play’ of regenerative medicine in horses: what the horse can tell the human. Regen Med. 2014; 9(5): 673-685.

[28] Galipeau J, Sensebé L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cytotherapy. 2018; 20(5): 565-569.

[29] Zhang G, Zhou X, Hu S, Jin Y, Qiu Z. Large animal models for the study of tendinopathy. Front Cell Dev Biol. 2022; 10:1031638.

[30] Marr N, Zamboulis DE, Werling D, et al. The tendon interfascicular basement membrane provides a vascular niche for CD146+ cell subpopulations. Front Cell Dev Biol. 2023; 10:1094124.

[31] Moulin D, Sellam J, Berenbaum F, Guicheux J, Boutet M-A. The role of the immune system in osteoarthritis: mechanisms, challenges and future directions. Nat Rev Rheumatol. 2025; 21(4): 221-236.

[32] Ningtyas MC, Ansharullah BA, Sutanto H, Prajitno JH. Beyond weight: exploring the nexus between obesity and osteoarthritis. Med Fam SEMERGEN. 2025; 51(6):102526.

[33] Trumble T, Groschen D, Ha N, Boyce M, Merritt K, Brown M. New urine biomarker assay compares to synovial fluid changes after acute joint injury in an equine model of osteoarthritis. Osteoarthr Cartil. 2012; 20(suppl 1):S91.

[34] Boyce M, Trumble T, Carlson C, Groschen D, Merritt K, Brown M. Non-terminal model of acute joint injury causes early osteoarthritis. Osteoarthr Cartil. 2013; 21(5): 746-755.

[35] Xia Y, Zheng S, Bidthanapally A. Depth-dependent profiles of glycosaminoglycans in articular cartilage by microMRI and histochemistry. J Magn Reson Imaging. 2008; 28(1): 151-157.

[36] Fugazzola M, Nissinen MT, Jäntti J, et al. Composition, architecture and biomechanical properties of articular cartilage in differently loaded areas of the equine stifle. Equine Vet J. 2024; 56(3): 573-585.

[37] Malda J, Benders KEM, Klein TJ, et al. Comparative study of depth-dependent characteristics of equine and human osteochondral tissue from the medial and lateral femoral condyles. Osteoarthr Cartil. 2012; 20(10): 1147-1151.

[38] Goodrich L, Choi V, Carbone BD, McIlwraith C, Samulski R. Ex vivo serotype-specific transduction of equine joint tissue by self-complementary adeno-associated viral vectors. Hum Gene Ther. 2009; 20(12): 1697-1702.

[39] Frisbie DD, Kawcak CE, McIlwraith CW, Werpy NM. Evaluation of polysulfated glycosaminoglycan or sodium hyaluronan administered intra-articularly for treatment of horses with experimentally induced osteoarthritis. Am J Vet Res. 2009; 70(2): 203-209.

[40] Frisbie DD, Kisiday JD, Kawcak CE, Werpy NM, McIlwraith CW. Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis. J Orthop Res. 2009; 27(12): 1675-1680.

[41] Nelson B, Kawcak C, Barrett M, McIlwraith C, Grinstaff M, Goodrich L. Recent advances in articular cartilage evaluation using computed tomography and magnetic resonance imaging. Equine Vet J. 2018; 50(5): 564-579.

[42] Jasiński T, Turek B, Kaczorowski M, et al. Equine models of temporomandibular joint osteoarthritis: a review of feasibility, biomarkers, and molecular signaling. Biomedicine. 2024; 12(3):542.

[43] Chiaradia E, Miller I. In slow pace towards the proteome of equine body fluids. J Proteome. 2020; 225:103880.

[44] Fukuda K, Mita H, Tamura N, et al. Characteristic inflammatory biomarkers in an equine model of persistent synovitis induced by the intra-articular administration of monoiodoacetic acid. J Equine Vet Sci. 2023; 127:104564.

[45] Kearney CM, Korthagen NM, Plomp SGM, et al. A translational model for repeated episodes of joint inflammation: welfare, clinical and synovial fluid biomarker assessment. Animals. 2023; 13(20):3190.

[46] Manfredi JM, Jacob S, Norton E. A one-health lens offers new perspectives on the importance of endocrine disorders in the equine athlete. J Am Vet Med Assoc. 2023; 261(2): 153-164.

[47] Roszkowski S. Therapeutic potential of mesenchymal stem cell-derived exosomes for regenerative medicine applications. Clin Exp Med. 2024; 24(1):46.

[48] Lakey J. Advances in mesenchymal stem cell therapy for equine osteoarthritis. Am J Biomed Sci Res. 2024; 22: 368-373.

[49] Ropka-Molik K, Opiela J, Piórkowska K, et al. Changes of gene expression profile during differentiation of equine bone marrow-derived MSCs towards adipocytes and chondrocytes. Ann Anim Sci. 2025; 26(1): 293-306.

[50] Hillmann A, Ahrberg AB, Brehm W, et al. Comparative characterization of human and equine mesenchymal stromal cells: a basis for translational studies in the equine model. Cell Transplant. 2016; 25(1): 109-124.

[51] Bellas E, Rollins A, Moreau JE, et al. Equine model for soft-tissue regeneration. J Biomed Mater Res B Appl Biomater. 2015; 103(6): 1217-1227.

[52] Sparks HD, Sigaeva T, Tarraf S, et al. Biomechanics of wound healing in an equine limb model: effect of location and treatment with a peptide-modified collagen–chitosan hydrogel. ACS Biomater Sci Eng. 2021; 7(1): 265-278.

[53] Chanda M, Petchdee S. Cardiac morphology changes in horses as a response to various types of sports. J Appl Anim Res. 2022; 50(1): 453-459.

[54] Barbier J, Ville N, Kervio G, Walther G, Carré F. Sports-specific features of athlete's heart and their relation to echocardiographic parameters. Herz Kardiovaskuläre Erkrankungen. 2006; 31(6): 531-543.

[55] Nath LC, Saljic A, Buhl R, et al. Histological evaluation of cardiac remodelling in equine athletes. Sci Rep. 2024; 14(1):16709.

[56] Carstensen H, Hesselkilde EZ, Haugaard MM, et al. Effects of dofetilide and ranolazine on atrial fibrillatory rate in a horse model of acutely induced atrial fibrillation. J Cardiovasc Electrophysiol. 2019; 30(4): 596-606.

[57] Premont A, Saadeh K, Edling C, Lewis R, Marr CM, Jeevaratnam K. Cardiac ion channel expression in the equine model—in-silico prediction utilising RNA sequencing data from mixed tissue samples. Physiol Rep. 2022; 10(14):e15273.

[58] Alberti E, Stucchi L, Lo Feudo CM, et al. Evaluation of cardiac arrhythmias before, during, and after treadmill exercise testing in poorly performing Standardbred racehorses. Animals. 2012; 11(8):2413.

[59] Navas de Solis C. Exercising arrhythmias and sudden cardiac death in horses: review of the literature and comparative aspects. Equine Vet J. 2016; 48(4): 406-413.

[60] Aune D, Schlesinger S, Hamer M, Norat T, Riboli E. Physical activity and the risk of sudden cardiac death: a systematic review and meta-analysis of prospective studies. BMC Cardiovasc Disord. 2020; 20(1):318.

[61] Lange-Consiglio A, Stucchi L, Zucca E, Lavoie JP, Cremonesi F, Ferrucci F. Insights into animal models for cell-based therapies in translational studies of lung diseases: is the horse with naturally occurring asthma the right choice? Cytotherapy. 2019; 21(5): 525-534.

[62] Fahy JV. Type 2 inflammation in asthma—present in most, absent in many. Nat Rev Immunol. 2015; 15(1): 57-65.

[63] Höglund N, Koho N, Rossi H, et al. Isolation of extracellular vesicles from the Bronchoalveolar lavage fluid of healthy and asthmatic horses. Front Vet Sci. 2022; 9:894189.

[64] Manfredi JM, Jacob SI, Boger BL, Norton EM. A one-health approach to identifying and mitigating the impact of endocrine disorders on human and equine athletes. Am J Vet Res. 2022; 84(2): 1-15.

[65] Johnson PJ, Wiedmeyer CE, LaCarrubba A, Ganjam VK, Messer NT. Diabetes, insulin resistance, and metabolic syndrome in horses. J Diabetes Sci Technol. 2012; 6(3): 534-540.

[66] Stefaniuk-Szmukier M, Piórkowska K, Ropka-Molik K. Equine metabolic syndrome: a complex disease influenced by multifactorial genetic factors. Genes (Basel). 2023; 14(8):1544.

[67] Reynolds A, Keen JA, Fordham T, Morgan RA. Adipose tissue dysfunction in obese horses with equine metabolic syndrome. Equine Vet J. 2019; 51(6): 760-766.

[68] Carter R, McCutcheon L, George Sjaarda L, Smith T, Frank N, Geor R. Effects of diet-induced gain on insulin sensitivity and plasma hormone and lipid concentrations in horses. Am J Vet Res. 2009; 70: 1250-1258.

[69] Marycz K, Szłapka-Kosarzewska J, Geburek F, Kornicka-Garbowska K. Systemic administration of rejuvenated adipose-derived mesenchymal stem cells improves liver metabolism in equine metabolic syndrome (EMS)—new approach in veterinary regenerative medicine. Stem Cell Rev Rep. 2019; 15(6): 842-850.

[70] Waller A, Huettner L, Kohler K, Lacombe V. Novel link between inflammation and impaired glucose transport during equine insulin resistance. Vet Immunol Immunopathol. 2012; 149(3–4): 208-215.

[71] Hodavance MS, Ralston S, Pelczer I. Beyond blood sugar: the potential of NMR-based metabonomics for type 2 human diabetes, and the horse as a possible model. Anal Bioanal Chem. 2007; 387(2): 533-537.

[72] Riddle D, Stratford P. Body weight changes and corresponding changes in pain and function in persons with symptomatic knee osteoarthritis: a cohort study. Arthritis Care Res. 2013; 65(1): 15-22.

[73] Bamford N, Potter S, Baskerville C, Harris P, Bailey S. Influence of dietary restriction and low-intensity exercise on weight loss and insulin sensitivity in obese equids. J Vet Intern Med. 2019; 33(1): 280-286.

[74] Delarocque J, Frers F, Huber K, Feige K, Warnken T. Weight loss is linearly associated with a reduction of the insulin response to an oral glucose test in Icelandic horses. BMC Vet Res. 2020; 16(1):151.

[75] Ertelt A, Barton AK, Schmitz RR, Gehlen H. Metabolic syndrome: is equine disease comparable to what we know in humans? Endocr Connect. 2014; 3(3): R81-R93.

[76] Ragno VM, Zello GA, Klein CD, Montgomery JB. From table to stable: a comparative review of selected aspects of human and equine metabolic syndrome. J Equine Vet Sci. 2019; 79: 131-138.

[77] Seok J, Warren HS, Cuenca AG, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci. 2013; 110(9): 3507-3512.

[78] Noronha LE, Harman RM, Wagner B, Antczak DF. Generation and characterization of monoclonal antibodies to equine CD16. Vet Immunol Immunopathol. 2012; 146(2): 135-142.

[79] Karagianni A, Kapetanovic R, Summers K, McGorum B, Hume D, Pirie R. Comparative transcriptome analysis of equine alveolar macrophages. Equine Vet J. 2017; 49(3): 375-382.

[80] Ayad A, Almarzook S, Besseboua O, et al. Investigation of cerebellar abiotrophy (CA), lavender foal syndrome (LFS), and severe combined immunodeficiency (SCID) variants in a cohort of three MENA region horse breeds. Genes. 2021; 12(12):1893.

[81] Wiler R, Leber R, Moore BB, VanDyk LF, Perryman LE, Meek K. Equine severe combined immunodeficiency: a defect in V(D)J recombination and DNA-dependent protein kinase activity. Proc Natl Acad Sci USA. 1995; 92(25): 11485-11489.

[82] Felippe MJ. Equine common variable immunodeficiency: lessons from 100 clinical cases. Equine Vet Educ. 2024; 36: 543-554.

[83] Horohov DW. The equine immune responses to infectious and allergic disease: a model for humans? Mol Immunol. 2015; 66(1): 89-96.

[84] Paillot R, Hannant D, Kydd J, Daly J. Vaccination against equine influenza: quid novi? Vaccine. 2006; 24(19): 4047-4061.

[85] Leroux C, Cadoré J-L, Montelaro R. Equine infectious anemia virus (EIAV): what has HIV's country cousin got to tell us? Vet Res. 2004; 35(4): 485-512.

[86] Dhondt KP, Horvat B. Henipavirus infections: lessons from animal models. Pathogens. 2013; 2(2): 264-287.

[87] Porcellato I, Mecocci S, Mechelli L, et al. Equine penile squamous cell carcinomas as a model for human disease: a preliminary investigation on tumor immune microenvironment. Cells. 2020; 9(11):2364.

[88] Podstawski P, Samiec M, Skrzyszowska M, Szmatoła T, Semik-Gurgul E, Ropka-Molik K. The induced expression of BPV E4 gene in equine adult dermal fibroblast cells as a potential model of skin sarcoid-like neoplasia. Int J Mol Sci. 2022; 23(4):1970.

[89] Yuan Z, Gallagher A, Gault EA, Campo MS, Nasir L. Bovine papillomavirus infection in equine sarcoids and in bovine bladder cancers. Vet J. 2007; 174(3): 599-604.

[90] Jindra C, Hainisch EK, Brandt S. Immunotherapy of equine sarcoids-from early approaches to innovative vaccines. Vaccines (Basel). 2023; 11(4):769.

[91] Nasir L, Reid SW. Bovine papillomaviral gene expression in equine sarcoid tumours. Virus Res. 1999; 61(2): 171-175.

[92] Hofmaier F, Hauck S, Amann B, Degroote R, Deeg C. Changes in matrix metalloproteinase network in a spontaneous autoimmune uveitis model. Invest Ophthalmol Vis Sci. 2011; 52(5): 2314-2320.

[93] Eberdt C, Amann B, Feuchtinger A, Hauck SM, Deeg CA. Differential expression of inwardly rectifying K+ channels and aquaporins 4 and 5 in autoimmune uveitis indicates misbalance in Müller glial cell-dependent ion and water homeostasis. Glia. 2011; 59: 697-707.

[94] Witkowski L, Cywinska A, Paschalis-Trela K, Crisman M, Kita J. Multiple etiologies of equine recurrent uveitis—a natural model for human autoimmune uveitis: a brief review. Comp Immunol Microbiol Infect Dis. 2016; 44: 14-20.

[95] Lees P, Higgins AJ, Sedgwick AD, May SA. Applications of equine models of acute inflammation. The Ciba-Geigy prize for research in animal health. Vet Rec. 1987; 120(22): 522-529.

[96] Karagianni AE, Lisowski ZM, Hume DA, Scott Pirie R. The equine mononuclear phagocyte system: the relevance of the horse as a model for understanding human innate immunity. Equine Vet J. 2021; 53(2): 231-249.

[97] Mayaki AM, Abdul Razak IS, Noraniza MA, Mazlina M, Rasedee A. Biofluid markers of equine neurological disorders reviewed from human perspectives. J Equine Vet Sci. 2020; 86:102907.

[98] Fortin JS, Hetak AA, Duggan KE, Burglass CM, Penticoff HB, Schott HC 2nd. Equine pituitary pars intermedia dysfunction: a spontaneous model of synucleinopathy. Sci Rep. 2021; 11(1):16036.

[99] Brault LS, Famula TR, Penedo MC. Inheritance of cerebellar abiotrophy in Arabians. Am J Vet Res. 2011; 72(7): 940-944.

[100] Abele M, Bürk K, Schöls L, et al. The aetiology of sporadic adult-onset ataxia. Brain. 2002; 125(5): 961-968.

[101] Aleman M, Finno CJ, Weich K, Penedo MCT. Investigation of known genetic mutations of Arabian horses in Egyptian Arabian foals with juvenile idiopathic epilepsy. J Vet Intern Med. 2018; 32(1): 465-468.

[102] Aleman M, Gray LC, Williams DC, et al. Juvenile idiopathic epilepsy in Egyptian Arabian foals: 22 cases (1985–2005). J Vet Intern Med. 2006; 20(6): 1443-1449.

[103] Aleman M, Benini R, Elestwani S, Vinardell T. Juvenile idiopathic epilepsy in Egyptian Arabian foals, a potential animal model of self-limited epilepsy in children. J Vet Intern Med. 2024; 38(1): 449-459.

[104] O' Brien C, O. Parker M, McBride S. Toward a diagnostic framework for the equine depressive phenotype: a narrative review. J Vet Behav. 2025; 79: 92-107.

[105] EDITION F. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association; 1980: 205-224.

[106] McBride S, Roberts K, Hemmings AJ, Ninomiya S, Parker MO. The impulsive horse: comparing genetic, physiological and behavioral indicators to those of human addiction. Physiol Behav. 2022; 254:113896.

[107] Horvath S, Haghani A, Peng S, et al. DNA methylation aging and transcriptomic studies in horses. Nat Commun. 2022; 13(1):40.

[108] Wiśniewska M, Janczarek I, Piwczyński D. The aging phenomenon of horses with reference to human–horse relations. J Equine Vet Sci. 2019; 73: 37-42.

[109] Pappas LE, Nagy TR. The translation of age-related body composition findings from rodents to humans. Eur J Clin Nutr. 2019; 73(2): 172-178.

[110] DeNotta S, McFarlane D. Immunosenescence and inflammaging in the aged horse. Immun Ageing. 2023; 20(1):2.

[111] Wagner PD. Determinants of V˙O₂max: man vs. horse. J Equine Vet Sci. 1995; 15(9): 398-404.

[112] Schrurs C, Dubois G, Patarin F, Cobb M, Gardner DS, Van Erck-Westergren E. Cardiovascular and locomotory parameters during training in thoroughbred racehorses: a multi-national study. Comp Exerc Physiol. 2022; 18(3): 185-200.

[113] Myćka G, Ropka-Molik K, Cywińska A, Szmatoła T, Stefaniuk-Szmukier M. Molecular insights into the lipid-carbohydrates metabolism switch under the endurance effort in Arabian horses. Equine Vet J. 2024; 56(3): 586-597.

[114] Avison A, Physick-Sheard PW, Pyle WG. Performance horses as a model for exercise-associated cardiac arrhythmias and sudden cardiac death. J Mol Cell Cardiol Plus. 2025; 12:100452.

[115] Witkowska-Piłaszewicz O, Malin K, Dąbrowska I, Grzędzicka J, Ostaszewski P, Carter C. Immunology of physical exercise: is Equus caballus an appropriate animal model for human athletes? Int J Mol Sci. 2024; 25(10):5210.

[116] Reißmann M, Rajavel A, Kokov ZA, Schmitt AO. Identification of differentially expressed genes after endurance runs in Karbadian horses to determine candidates for stress indicators and performance capability. Genes (Basel). 2023; 14(11):1982.

[117] Myćka G, Ropka-Molik K, Cywińska A, Stefaniuk-Szmukier M. Endurance effort affected expression of Actinin 3 and klotho different isoforms basing on the Arabian horses model. Genes. 2024; 15(12):1618.

[118] Peña O, del Enriquez Castillo L, González-Chávez S, et al. Prevalence of polymorphism and post-training expression of ACTN3 (R/X) and ACE (I/D) genes in CrossFit athletes. Int J Environ Res Public Health. 2023; 20:4404.

[119] Carnevale EM, Catandi GD, Fresa K. Equine aging and the oocyte: a potential model for reproductive aging in women. J Equine Vet Sci. 2020; 89:103022.

[120] Rizzo M, du Preez N, Ducheyne KD, et al. The horse as a natural model to study reproductive aging-induced aneuploidy and weakened centromeric cohesion in oocytes. Aging (Albany NY). 2020; 12: 22220-22232.

[121] Manfredi JM, Jacob SI, Boger BL, Norton EM. A one-health approach to identifying and mitigating the impact of endocrine disorders on human and equine athletes. Am J Vet Res. 2023; 84(2).ajvr.22.11.0194.

[122] Burnett M, Norton E. Advancing equine health through genetic and environmental research: a one health approach. Am J Vet Res. 2025; 86(5):ajvr.25.03.0079.

[123] Ferreira-Dias GM, Alpoim-Moreira J, Szóstek-Mioduchowska A, Rebordão MR, Skarzynski DJ. The path to fertility: current approaches to mare endometritis and endometrosis. Anim Reprod. 2024; 21(3):e20240070.

[124] Lawson JM, Salem SE, Miller D, et al. Naturally occurring horse model of miscarriage reveals temporal relationship between chromosomal aberration type and point of lethality. Proc Natl Acad Sci. 2024; 121(33):e2405636121.

[125] Cortez JV, Hardwicke K, Cuervo-Arango J, Grupen CG. Cloning horses by somatic cell nuclear transfer: effects of oocyte source on development to foaling. Theriogenology. 2023; 203: 99-108.

[126] Benammar A, Derisoud E, Vialard F, et al. The Mare: a pertinent model for human assisted reproductive technologies? Animals. 2021; 11(8):2304.

[127] Ribitsch I, Baptista PM, Lange-Consiglio A, et al. Large animal models in regenerative medicine and tissue engineering: to do or not to do. Front Bioeng Biotechnol. 2020; 8:972.

[128] Gray M, Guido S, Kugadas A. Editorial: the use of large animal models to improve pre-clinical translational research. Front Vet Sci. 2022; 9:1086912.

[129] Lönker NS, Fechner K, Abd El Wahed A. Horses as a crucial part of one health. Vet Sci. 2020; 7(1):28.

[130] Young R, Bush SJ, Lefevre L, et al. Species-specific transcriptional regulation of genes involved in nitric oxide production and arginine metabolism in macrophages. Immunohorizons. 2018; 2(1): 27-37.

[131] Kapetanovic R, Fairbairn L, Beraldi D, et al. Pig bone marrow-derived macrophages resemble human macrophages in their response to bacterial lipopolysaccharide. J Immunol. 2012; 188(7): 3382-3394.

[132] Wade C, Giulotto E, Sigurdsson S, et al. Genome sequence, comparative analysis, and population genetics of the domestic horse. Science. 2009; 326(5954): 865-867.

[133] Swinburne JE, Bogle H, Klukowska-Rötzler J, et al. A whole-genome scan for recurrent airway obstruction in warmblood sport horses indicates two positional candidate regions. Mamm Genome. 2009; 20(8): 504-515.

[134] Milenkovic D, Oustry-Vaiman A, Lear TL, et al. Cytogenetic localization of 136 genes in the horse: comparative mapping with the human genome. Mamm Genome. 2002; 13(9): 524-534.

[135] Steinbach F, Stark R, Ibrahim S, et al. Molecular cloning and characterization of markers and cytokines for equid myeloid cells. Vet Immunol Immunopathol. 2005; 108(1–2): 227-236.

[136] Tompkins D, Hudgens E, Horohov D, Baldwin CL. Expressed gene sequences of the equine cytokines interleukin-17 and interleukin-23. Vet Immunol Immunopathol. 2010; 133(2–4): 309-313.

[137] Hudgens E, Tompkins D, Boyd P, Lunney JK, Horohov D, Baldwin CL. Expressed gene sequence of the IFNγ-response chemokine CXCL9 of cattle, horses, and swine. Vet Immunol Immunopathol. 2011; 141(3–4): 317-321.

[138] Moro LN, Viale DL, Bastón JI, et al. Generation of myostatin edited horse embryos using CRISPR/Cas9 technology and somatic cell nuclear transfer. Sci Rep. 2020; 10(1):15587.

[139] Raudsepp T, Finno CJ, Bellone RR, Petersen JL. Ten years of the horse reference genome: insights into equine biology, domestication and population dynamics in the post-genome era. Anim Genet. 2019; 50(6): 569-597.

[140] Coleman SJ, Zeng Z, Hestand MS, Liu J, Macleod JN. Analysis of unannotated equine transcripts identified by mRNA sequencing. PLoS One. 2013; 8(7):e70125.

[141] Lossi L. Anatomical features for an adequate choice of the experimental animal model in biomedicine: III. Ferret, goat, sheep, and horse. Ann Anat. 2022; 244:151978.

Rights & permissions

2026 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.